Biosimilars 2017 Global Market Expected to Grow at CAGR 55.52% and Forecast to 2021
The analysts forecast the global biosimilars market to grow at a CAGR of 55.52% during the period 2016-2020.
Pune, India – August 17, 2017 /MarketersMedia/ —
Global Biosimilars Market
Biosimilars are defined as the follow-on versions of original biological medicines. These are separately developed after the patent protecting the original product has expired. Biosimilars are intended to have the same MOA as original biological drugs and are designed to treat the same diseases as the innovator’s product. They have many similarities, but are not identical to, the reference biopharmaceutical product.
The analysts forecast the global biosimilars market to grow at a CAGR of 55.52% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global biosimilars market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of products such as somatropin, erythropoietin, colony-stimulating factors (CSF), interferons, interleukins, insulin and insulin analogs, follicle stimulating hormones (FSH), monoclonal antibodies (mAbs), and low molecular weight heparins (LMWH).
Get Sample Report @ https://www.wiseguyreports.com/sample-request/592563-global-biosimilars-market-2016-2020
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
The Global Biosimilars Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Biocon
• Celltrion
• Dr. Reddy’s Laboratories
• Hospira
• Sandoz
• STADA
• Teva Pharmaceuticals
Other prominent vendors
• 3SBio
• Accord Healthcare
• AET Biotech
• Allergan
• Alvartis Pharma
• Amega Biotech
• Amgen
• Apotex
• Aspen
• AstraZeneca
• Aurobindo Pharma
• Baxter
• Bharat Serums
• Bio Sidus
• Biogen
• Bionovis
• Bioton
• BioXpress Therapeutics
• Boehringer Ingelheim
• Boston Oncology
• Cipla
• Coherus Biosciences
• Daiichi Sankyo
• Emcure Pharmaceuticals
• Gedeon Richter
• GeneScience Pharmaceuticals
• GSK
• Hetero Drugs
• iBio
• Intas Pharmaceuticals
• JCR Pharmaceuticals
• LG Lifesciences
• Lonza
• Merck
• Mitsubishi Tanabe Pharma
• Momenta Pharmaceuticals
• Mylan
• Natco Pharma
• Novartis
• Pfenex
• Pfizer
• Ranbaxy Laboratories
• Roche Holding
• Samsung Biologics
• Sanofi
• Synthon
• Wockhardt
• Zydus Cadila Healthcare
Market driver
• Rise in number of patent expiries
• For a full, detailed list, view our report
Market challenge
• Physicians reluctance to prescribe biosimilars
• For a full, detailed list, view our report
Market trend
• Emergence of biosimilars
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
Complete Report Details @ https://www.wiseguyreports.com/reports/592563-global-biosimilars-market-2016-2020
Table of Contents -Major Key Points
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
• Assumptions
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Biosimilars: Overview
• Comparative analysis of biosimilars and generic small molecules
• Biosimilars market opportunities
• Challenges for new entrants
• Bio-betters
PART 05: Pipeline portfolio
PART 06: Market landscape
• Market overview
• Five forces analysis
PART 07: Market segmentation by application
• Global blood disorders biosimilars market
• Market overview
• Global oncology biosimilars market
• Global chronic and autoimmune diseases biosimilars market
• Global growth hormone deficiency biosimilars market
• Global infectious diseases biosimilars market
• Others
PART 08: Market segmentation by end-user
• Hospitals
• Retail pharmacies
PART 09: Geographical segmentation
• Global biosimilars market by geographical segmentation 2015-2020
• Biosimilars market in EMEA
• Biosimilars market in APAC
• Biosimilars market in Americas
PART 10: Market drivers
• Rise in number of patent expiries
• Need for cost-effective treatment
• Reimbursement benefits for biosimilars
• Favorable government regulations
• Promising pipeline
PART 11: Impact of drivers
PART 12: Market challenges
• Physicians reluctance to prescribe biosimilars
• Multiple manufacturing complexities
• Risks related to drug failure
• Limited availability of biosimilar products
• Difficulties in patient recruitment for conducting clinical trials
PART 13: Impact of drivers and challenges
PART 14: Market trends
• Emergence of biosimilars
• Outsourcing of biosimilar manufacturing activities
• Need for high investment in R&D
• High growth in the emerging markets
• Rising number of strategic collaborations
PART 15: Vendor landscape
• Competitive scenario
• Sandoz
• Hospira
• Teva Pharmaceuticals
• STADA
• Biocon
• Celltrion
• Dr. Reddy’s
• Other prominent vendors
………..CONTINUED
Buy Now@ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=592563
Contact Info:
Name: Norah Trent
Email: Sales@wiseguyreports.com
Organization: WiseGuy Research Consultants Pvt. Ltd.
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Phone: +1-646-845-9349
For more information, please visit https://www.wiseguyreports.com
Source: MarketersMedia
Release ID: 230194
Copyright © 1999-2013 SproutNews.com
